Rodin Therapeutics

Rodin Therapeutics is targeting epigenetics, or changes in gene expression, to develop therapeutics for cognitive impairment in Alzheimer’s disease and other neurological disorders.

Headquarters Cambridge, MA
Website www.rodintherapeutics.com​
Pipeline Preclinical